| Amgros 2027 2.1390.b | Amgros I/S | Orifarm A/S, Sandoz A/S, 2care4 ApS, Karo Healthcare AB, Orion Pharma A/S, Karo Healthcare AB, Orion Pharma A/S, Øresund Pharma ApS, Krka Sverige AB, 2care4 ApS, Krka Sverige AB, 2care4 ApS, Teva Denmark A/S, Teva Denmark A/S, Krka Sverige AB, Teva Denmark A/S, Krka Sverige AB, Sandoz A/S, 2care4 ApS, Krka Sverige AB, Krka Sverige AB, Orifarm A/S, 2care4 ApS | 59.180.427 kr. | 22. oktober 2026 |
| Amgros 2027 2.1390.b | Amgros I/S | Orifarm A/S, Sandoz A/S, 2care4 ApS, Karo Healthcare AB, Orion Pharma A/S, Karo Healthcare AB, Orion Pharma A/S, Øresund Pharma ApS, Krka Sverige AB, 2care4 ApS, Krka Sverige AB, 2care4 ApS, Teva Denmark A/S, Teva Denmark A/S, Krka Sverige AB, Teva Denmark A/S, Krka Sverige AB, Sandoz A/S, 2care4 ApS, Krka Sverige AB, Krka Sverige AB, Orifarm A/S, 2care4 ApS | 59.180.427 kr. | 22. oktober 2026 |
| Amgros 2027 1.701.a | Amgros I/S | Macure Pharma ApS, B. Braun Medical A/S, Macure Pharma ApS, Vantive ApS, Vantive ApS, Orifarm A/S, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Amgen Filial Af Amgen Ab Sverige, Galderma Nordic AB, Galenica AB, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Orion Pharma A/S, Teva Denmark A/S, Strides Nordic ApS, GHN Pharma Nordic AB, Macure Pharma ApS, Novartis Healthcare A/S, Zentiva Denmark ApS, Zentiva Denmark ApS, Orion Pharma A/S | 899.151.051 kr. | 15. oktober 2026 |
| Amgros 2027 1.701.a | Amgros I/S | Macure Pharma ApS, B. Braun Medical A/S, Macure Pharma ApS, Vantive ApS, Vantive ApS, Orifarm A/S, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Amgen Filial Af Amgen Ab Sverige, Galderma Nordic AB, Galenica AB, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Orion Pharma A/S, Teva Denmark A/S, Strides Nordic ApS, GHN Pharma Nordic AB, Macure Pharma ApS, Novartis Healthcare A/S, Zentiva Denmark ApS, Zentiva Denmark ApS, Orion Pharma A/S | 899.151.051 kr. | 15. oktober 2026 |
| Amgros 2027 2.212.a | Amgros I/S | Orion Pharma A/S, Orion Pharma A/S, 2care4 ApS, Teva Denmark A/S, Teva Denmark A/S, 2care4 ApS, Abacus Medicine A/S, Abacus Medicine A/S, 2care4 ApS, Chiesi Pharma AB, Orion Pharma A/S, Orion Pharma A/S, Paranova Danmark A/S, 2care4 ApS, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB | 33.641.330 kr. | 13. oktober 2026 |
| Amgros 2027 2.212.a | Amgros I/S | Orion Pharma A/S, Orion Pharma A/S, 2care4 ApS, Teva Denmark A/S, Teva Denmark A/S, 2care4 ApS, Abacus Medicine A/S, Abacus Medicine A/S, 2care4 ApS, Chiesi Pharma AB, Orion Pharma A/S, Orion Pharma A/S, Paranova Danmark A/S, 2care4 ApS, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB | 33.641.330 kr. | 13. oktober 2026 |
| Amgros 2027 2.212.a | Amgros I/S | Orion Pharma A/S, Orion Pharma A/S, 2care4 ApS, Teva Denmark A/S, Teva Denmark A/S, 2care4 ApS, Abacus Medicine A/S, Abacus Medicine A/S, 2care4 ApS, Chiesi Pharma AB, Orion Pharma A/S, Orion Pharma A/S, Paranova Danmark A/S, 2care4 ApS, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB | 33.641.330 kr. | 13. oktober 2026 |
| Amgros 2027 2.212.a | Amgros I/S | Orion Pharma A/S, Orion Pharma A/S, 2care4 ApS, Teva Denmark A/S, Teva Denmark A/S, 2care4 ApS, Abacus Medicine A/S, Abacus Medicine A/S, 2care4 ApS, Chiesi Pharma AB, Orion Pharma A/S, Orion Pharma A/S, Paranova Danmark A/S, 2care4 ApS, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB | 33.641.330 kr. | 13. oktober 2026 |
| Amgros 2027 1.700.a | Amgros I/S | Macure Pharma ApS, Swedish Orphan Biovitrum AB, Swedish Orphan Biovitrum AB, Orifarm Generics A/S, Recordati AB, Viatris ApS, Orifarm A/S, Ferring Lægemidler A/S, Orifarm A/S, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Orion Pharma A/S, Orion Pharma A/S, Ferring Lægemidler A/S, Orifarm A/S, Viatris ApS, AstraZeneca A/S, AstraZeneca A/S, FrostPharma AB, FrostPharma AB, Sanofi A/S, BioMarin International Limited, Takeda Pharma A/S, BioMarin International Limited, Chiesi Pharma AB, Øresund Pharma ApS, Takeda Pharma A/S, Viatris ApS, Øresund Pharma ApS | 419.427.587 kr. | 12. oktober 2026 |
| Amgros 2027 1.700.a | Amgros I/S | Macure Pharma ApS, Swedish Orphan Biovitrum AB, Swedish Orphan Biovitrum AB, Orifarm Generics A/S, Recordati AB, Viatris ApS, Orifarm A/S, Ferring Lægemidler A/S, Orifarm A/S, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Orion Pharma A/S, Orion Pharma A/S, Ferring Lægemidler A/S, Orifarm A/S, Viatris ApS, AstraZeneca A/S, AstraZeneca A/S, FrostPharma AB, FrostPharma AB, Sanofi A/S, BioMarin International Limited, Takeda Pharma A/S, BioMarin International Limited, Chiesi Pharma AB, Øresund Pharma ApS, Takeda Pharma A/S, Viatris ApS, Øresund Pharma ApS | 419.427.587 kr. | 12. oktober 2026 |
| Amgros 2027 1.1052.b | Amgros I/S | Biocon Biologics Ireland Limited, Orion Pharma A/S, Pfizer ApS, Samsung Bioepis NL B.V., Accord Healthcare AB, Roche Pharmaceuticals A/S, Orifarm A/S, Abacus Medicine A/S, 2care4 ApS | 704.000.000 kr. | 21. september 2026 |